At the Roswell Park Cancer Institute in New York, Mikhail Blagosklonny is a master and one of the most respected figures in the oncology field, being one of the best scientists in the area of cancer and aging. Like a scientist who studies cancer, he has already contributed a lot towards researches about the best therapies and methods of stopping the spreading of the tumors, and, regarding aging, he has helped with his discoveries about the popular cancer drug rapamycin as a possible treatment for life extension, which no one was talking about.
You can find work Mikhail Blagosklonny everywhere on the internet, as he is the editor-in-chief of Aging, a very respected newsletter about the process of becoming old; Cell Cycle, which talks about characteristics at the molecular level; and Oncotarget, a prize-winning online free newsletter that releases every week lots of information about the most varied subjects, but, more importantly, news and insightful peer-reviews on the world of Oncology.
Both his M.D. in internal medicine and his Ph.D. in experimental medicine and cardiology were obtained by the doctor from the “First Pavlov State Medical University,” located in St. Petersburg, Russia.
The Russian boy grew next to the place where he went to study, and Mikhail Blagosklonny has achieved a lot in the field of medicine through constant dedication and by improving his capabilities over and over again by being one of the best students of Oncology and of the cancer disease at his time.
On 2015, the specialist released an article about the anti-aging drug of today, where he states a few of the misconceptions about the process of aging and how the society thinks that aging is a body decline caused by the accumulation of random molecular damage. In the article, he proves that this is not entirely accurate, and there are methods of preventing the process of aging, simply by following a few of the steps that he has gathered through his extensive years of studying the subject.
The theory that this is completely false is the hyperfunction theory, where scientists believe that the process of aging is a continuation of the natural growing of your body. Among the options that can be used to extend the life of humans, Dr. Mikhail Blagosklonny accentuates the use of rapamycin and other rapalogs, which increases the extension of the healthy life and prevents diseases that become more common with aging.
This method is called the TOR-centric model because it targets the TOR (Target of Rapamycin), and that allows for the process of aging to be deaccelerated. The method has been called the fountain of youth in the headlines of dozens of newsletters about the topic across the world, and, not a few years ago, the TOR-centric drug usage was negatively seen because of the lack of view and evidence of scientists of that time. View Mikhail’s profile on Google Scholar
According to the specialist, there are three sources for the model that is being discussed all around the world, and those are the genetics that promotes longevity and longer lifespan; cellular senescence, and finally, diseases obviously have a high impact on the factor.
To learn more about the study, visit Mikhail Blagosklonny’s award-winning Oncotarget journal.